Whether this evolutionary explanation is true or not, identification of mechanisms by which leptin physiologic action becomes saturated at relatively low leptin levels might suggest therapeutic approaches to enhancing leptin action to treat obesity. The gene discussed is LEP; the disease is obesity disorder.